Macular degeneration is a heterogeneous group of disorders characterized by photoreceptor degeneration and atrophy of the retinal pigment epithelium (RPE) in the central retina. An autosomal dominant form of Stargardt macular degeneration (STGD) is caused by mutations in ELOVL4, which is predicted to encode an enzyme involved in the elongation of long-chain fatty acids. We generated transgenic mice expressing a mutant form of human ELOVL4 that causes STGD. In these mice, we show that accumulation by the RPE of undigested phagosomes and lipofuscin, including the fluorophore, 2-[2,6-dimethyl-8-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1E,3E,5E,7E-octatetraenyl]-1-(2-hyydroxyethyl)-4-[4-methyl-6-(2,6,6,-trimethyl-1-cyclohexen-1-yl)-1E,3E,5E-hexatrienyl]-pyridinium (A2E) is followed by RPE atrophy. Subsequently, photoreceptor degeneration occurs in the central retina in a pattern closely resembling that of human STGD and age-related macular degeneration. The ELOVL4 transgenic mice thus provide a good model for both STGD and dry age-related macular degeneration, and represent a valuable tool for studies on therapeutic intervention in these forms of blindness.phagosome ͉ Stargardt disease ͉ photoreceptor ͉ retinal pigment epithelium M acular degeneration involves the death of photoreceptor cells in the central retina, which is responsible for fine-detail vision. Age-related macular degeneration (AMD) affects Ϸ30% of people over the age of 75 (1, 2), and is becoming a greater health problem with the rapidly growing elderly population of developed countries. There is no treatment to halt or reverse the disease for the dry form, which comprises Ϸ90% of AMD cases. Moreover, there is a lack of suitable animal models for experimentation on therapies for dry AMD. Stargardt macular dystrophy (STGD) shares pathological features with AMD, except that it occurs at a young age. Both AMD and STGD are characterized by the accumulation of high levels of lipofuscin in the retinal pigment epithelium (RPE), which precedes degeneration of the photoreceptors in the macula and RPE atrophy.The gene responsible for an autosomal dominant form of STGD, STDG3, was identified recently as ELOVL4 (3, 4). It is predicted to encode an enzyme involved in the elongation of very long-chain fatty acids (hence the name, ELOVL), and is highly expressed in rod and cone photoreceptor cells (5, 6). Sequence analysis of human ELOVL4 cDNA predicts a protein of 314 aa that shares homology with members of the yeast Elo (elongation of long chain fatty acid) family and the human ELO1 homolog (HELO1) (3). HELO1 and the ELO family members possess biochemical features that suggest their participation in reduction reactions occurring during fatty acid elongation (7,8). Mutational analysis of the ELOVL4 gene in five large STGD-like macular dystrophy pedigrees revealed a 5-bp deletion, resulting in a frame-shift and the introduction of a stop codon, 51 codons from the end of the coding region (3). Subsequently, two 1-bp deletions, 789delT and 794delT, in ELOVL4 were identifi...